Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen people stop taking Wegovy, most experience a gradual return of appetite and, over time, a partial or full regain of the weight lost during treatment. This is not a personal failure. It reflects the biological reality that semaglutide manages the hormonal signals driving hunger; once it leaves the body, those signals reassert themselves. Wegovy is a prescription-only medicine, and any decision to stop or pause it should be made with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide has a half-life of approximately one week, which means it takes around five weeks after your last injection for the medicine to fall to negligible levels in your system. During that window, the effects don't vanish overnight. Nausea or other gastrointestinal symptoms you may have grown used to on Wegovy will ease first. Appetite begins creeping back in, usually within the first two to three weeks, though the timing differs from person to person.
Some people describe this phase as surprisingly gradual; others find the return of hunger quite abrupt. Either pattern is normal. Your body is re-adjusting to managing appetite without the GLP-1 signalling that semaglutide was providing. If you have questions about what happens when you stop Wegovy, including how the medicine leaves your system and what to expect from your own body during this period, the detailed guide on what happens after you stop taking Wegovy covers the physiological timeline in more depth.
Importantly, stopping does not undo the metabolic or cardiovascular benefits immediately; those take longer to dissipate. But the hunger-suppressing effect is the first thing to fade, and that matters for what comes next.
This is the part that catches many people off guard. Feeling hungry again does not mean the treatment failed. Obesity is a condition shaped by biology, not willpower, and the hormonal environment that drove weight gain before treatment is still there when the medicine stops. Clinical evidence makes this clear: the STEP 1 withdrawal trial, published in the New England Journal of Medicine, found that participants who stopped semaglutide after 68 weeks regained, on average, two-thirds of the weight they had lost within a year, while those who continued maintained their results. That is a significant gap.
If you are curious about how different stopping scenarios play out, our overview of outcomes after Wegovy links through to further reading. The key message from the evidence is that the medicine is working for as long as it is being taken, and the biology reasserts itself once it is not. This is why ongoing clinical supervision matters so much: your prescriber can help you plan around this reality rather than simply encounter it.
Deciding to stop Wegovy is rarely as simple as it sounds. There are several common reasons: cost, side effects that haven't settled, a planned surgery or pregnancy, or a feeling that you have reached a stable weight and want to see how you fare. Each of those reasons calls for a different conversation with your prescriber.
For context on what the ongoing cost of treatment looks like, our Wegovy price comparison guide sets out what private treatment typically costs in the UK and what a transparent service includes. Cost pressures are a legitimate thing to raise with a clinician rather than reason to stop quietly and alone.
If you are stopping because of side effects, your prescriber may suggest a dose reduction or a temporary pause rather than full discontinuation. If you are stopping ahead of surgery, NHS England guidance is clear that your healthcare team, including your anaesthetist, should know you are taking or recently stopped a GLP-1 medicine. And if you are stopping because you are thinking about pregnancy, there is a recommended wash-out period before trying to conceive, something your prescriber will walk you through. The right next step really does depend on why you are stopping, and if you want to understand what happens if you stop Wegovy in different circumstances, our guide explores those scenarios in detail. You can also read about what happens after you stop Wegovy to get a clearer picture of the changes that follow once treatment ends.
The evidence on weight regain does not mean that stopping Wegovy leads inevitably to returning to your starting point. What people do in the months after stopping makes a real difference. Maintaining the dietary habits built during treatment, keeping up physical activity, and staying in contact with clinical support all slow the rate of regain. It is much easier to preserve changes while the new habits are still fresh than to rebuild them after significant weight has returned.
The NHS England guidance on weight management injections emphasises this directly: these medicines are intended to be used alongside dietary change and increased activity, and that lifestyle component remains the longer-term infrastructure after treatment ends. Some people also transition to a different medicine, or return to Wegovy later after a planned break. Our weight loss treatment overview covers the options that may be relevant depending on your circumstances.
If you are weighing up whether to restart, pause, or try a different approach, our prescribers are available seven days a week. Check your eligibility and a GPhC-registered prescriber will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.